6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

Item
http://www.wikidata.org/entity/Q34460119
Altered striatal function in a mutant mouse lacking D1A dopamine receptorsInduction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activationDopamine transporter gene variation modulates activation of striatum in youth with ADHDEnhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats.Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvementLong-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist.Portraying G protein-coupled receptors with fluorescent ligandsL-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro studyChronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivityStriatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression.
P2860

6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

Item
http://www.wikidata.org/entity/Q34460119
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@ast
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@en
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@nl
type
label
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@ast
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@en
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@nl
prefLabel
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@ast
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@en
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@nl
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932
P1433
P1476
6-hydroxydopamine treatments e ...... g dopamine antagonist binding.
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932